Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Prof Oriel Thekisoe receives prestigious TW Kambule NRF-NSTF Award
2014-07-07

 Prof Oriel Thekisoe
Photo: Sonia Small
Prof Oriel Thekisoe from the UFS was named recipient of the prestigious TW Kambule NRF-NSTF Award. The announcement was made during the 16th Annual NSTF-BHP Billiton 2013/2014 Awards Gala Dinner held in Johannesburg on Thursday 3 July 2014.

Prof Thekisoe is an Associate Professor in the university's Department of Zoology and Entomology at the Qwaqwa Campus.

He has been recognised as an emerging researcher for his outstanding contribution to Science, Engineering and Technology (SET).

"It is a great honour for the university to learn that Prof Thekisoe has won the award of the National Science and Technology Forum. This is a very competitive award and speaks of the quality and depth of talent at the UFS as we prepare the next generation of scientists and scholars,” said Vice-Chancellor and Rector of the UFS, Prof Jonathan Jansen.

"I hope that the award will inspire our current science students to work harder in pursuing the discovery of new methods and techniques which will improve our livelihoods,” Prof Thekisoe said after receiving the award from the Minister of Science and Technology, Ms Naledi Pandor. “I am grateful to the Dean of the Faculty of Natural and Agricultural Sciences, Prof Neil Heideman, for believing in me. I am also grateful to my former lecturers, Profs Peter Mbati, who is now the Rector of the University of Venda, and Noboru Inoue, from Japan’s Obihiro University, for grooming and inspiring the scientist in me.”

"Prof Thekisoe is at the forefront of the research development activities at the Qwaqwa Campus,” said Prof Corli Witthuhn, Vice-Rector: Research at the UFS. “He serves as a mentor to many of the younger scholars on the campus. As one of the Vice-Chancellor's Prestige Scholars at the university, he has the potential to become one of the most prominent researchers in his field in the country."

The Vice-Chancellor’s Prestige Programme (PSP) supports the accelerated scholarship of junior UFS researchers in the first five years after obtaining their PhDs. The prestige scholars participate in an intensive programme of support that includes international placement and intensive mentorship.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept